Feed / ZLAB

Zai Lab Limited

ZLAB

Healthcare · 26.01 -0.0% today

Isolated · not yet confirmedMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

Zai Lab Limited's current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 21 directly disclosed connections are confirming.

Company-0.0% todayVolume comparison unavailable
Market group0 of 1 activeBiotechnology · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • In April 2026 ZLAB announced a global clinical trial collaboration with Amgen to evaluate zoci in combination with Amgen’s IMDELLTRA (tarlatamab-dlle) for ES-SCLC.

Invalidation: The isolated read changes if ZLAB's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind ZLAB

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

AMGNAmgen Inc.partnerMay 7, 2026

In April 2026, we announced a global clinical trial collaboration with Amgen to evaluate zoci in combination with Amgen’s IMDELLTRA ® (tarlatamab-dlle), a DLL3/CD3 bispecific T-cell engager, for ES-SCLC and a clinical collaboration with Boehringer Ingelheim t…

NVCRNovoCure LimitedpartnerAug 7, 2025

Tumor Treating Fields (TTFields): In May 2025, our partner NovoCure presented results from the Phase III PANOVA-3 trial of TTFields therapy for pancreatic cancer at the 2025 ASCO Annual Meeting and simultaneously published in the Journal of Clinical Oncology.

Depended on by

NVCRNovoCure LimitedpartnerApr 30, 2026

In 2018, we granted Zai Lab (Shanghai) Co., Ltd.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 23 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

ZLAB is currently a Leader in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for ZLAB; it is not active in the latest market snapshot.